Portfolio

1 | 2 | 3 | 4

Hydra Biosciences

Cambridge, MA-based Hydra Biosciences is developing ion channel drugs to treat pain and inflammation. The company is currently focused on the Transient Receptor Potential (TRP) family of ion channels, which offers numerous drug discovery opportunities.

HydroCision

» www.hydrocision.com

Based in North Billerica, MA, Hydrocision is currently developing a broad range of fluidjet-based products to meet the needs of spine specialists. The company’s FDA-approved devices quickly, precisely, and selectively cut and evacuate hard and soft tissue safely and continuously giving the spine surgeon an excellent alternative to hand tools and RF devices. Co-investors include Oxford Bioscience Partners and Triathlon Medical Ventures.

Phase Forward (NASDAQ:PFWD)

» www.phaseforward.com

Phase Forward provides integrated data collection and data management solutions for clinical trials and drug safety, automating and integrating the management of the entire clinical development process. The company is headquartered in Waltham, Massachusetts. Founded in 1997, Phase Forward completed a successful IPO in 2004.

Pintex Pharmaceuticals (Acquired by Vernalis)

» www.vernalis.com

Pintex Pharmaceuticals discoverered and developed the Pin1 enzyme, a tumor marker that has been linked to numerous human cancers. The Watertown, MA-based company sold its assets and IP rights to UK-based Vernalis in 2005.

1 | 2 | 3 | 4

"As a CEO, I value both BioVentures Investors' experience in building shareholder value and their background as founders and advisors to emerging companies."

Peter Vitulli
President & CEO
Sciona

» Read Success Story

"BioVentures Investors brings a wealth of operating experience and scientific knowledge."

Stella M. Sung, Ph.D.
Chief Business Officer
Cylene Pharmaceuticals

» Read Success Story

"I'd call BioVentures Investors a 'user-friendly' venture capital firm. They understand technology development timelines and the issues related to medical devices."

Steven J. Tallarida
President Spirus Medical and ,
Founder AngioLink Corporation.

» Read Success Story

"What really sets them apart is their maturity, their understanding of the whole world of start-ups and what it takes to get a new idea and technology off the ground."

James Lousararian
President & CEO
Verax Biomedical

» Read Success Story